Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth.
about
Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?Current insights in to the pathophysiology of Irritable Bowel Syndrome.Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactionsThe prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.New horizons for the infectious diseases specialist: how gut microflora promote health and disease.Case studies of antibiotic therapy in the management of functional gastrointestinal disorders.Irritable bowel syndrome, gut microbiota and probiotics.Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage.The comparison of treatments with and without azithromycin in irritable bowel syndrome with diarrhea-predominant in gastrointestinal Clinic of Al-Zahra Hospital, Isfahan, Iran.Serial Frozen Fecal Microbiota Transplantation in the Treatment of Chronic Intestinal Pseudo-obstruction: A Preliminary Study.Chronic gastrointestinal consequences of acute infectious diarrhea: evolving concepts in epidemiology and pathogenesis.Altered intestinal microbiota in irritable bowel syndrome.Gastrointestinal motility disorder assessment in systemic sclerosis.Close association between intestinal microbiota and irritable bowel syndrome.Lactulose Breath Test Gas Production in Childhood IBS Is Associated With Intestinal Transit and Bowel Movement Frequency.A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
P2860
Q21261900-514CC555-A586-4029-8878-1F42410E1A71Q33875272-0478846C-2923-4D3D-88DE-81B595BD4522Q33916182-7576BDF9-A5F1-49A4-AE4E-0E0349EFC567Q33958897-5A021851-E0A9-4E24-B7AD-A604FA0CCE04Q34248518-942E6AE6-9C16-433A-9BC5-6BA2BD8D877EQ34590794-3D9CE490-ED46-4A37-9432-738A2191DEA6Q34780670-E0860CBC-FD00-4C1A-9136-F49339DE203CQ34985950-AEDE0DDF-DF0D-4EF1-8487-2FC3FF8E77CFQ35161373-8B6E9489-B2C3-4909-803D-CBC92EBABB85Q35450209-F7B345DB-1A9D-4CDE-87AE-02F2155A2A1BQ36073385-ED4DFBC6-75F2-4918-9594-7A509F6B57FFQ37504612-06B65CC3-AEA9-4E35-99F3-5EB888F50FFAQ37740030-A4FC8666-B0B7-4FD3-8827-1694010D21CFQ38003044-9EFBBADC-322E-4E01-9612-33D8AC45C2FBQ43087780-AD00E850-223B-4199-98A0-A64AB9C56930Q43575031-05FCCE08-A6E3-4DE0-B0B9-BC3088E7D7D0Q46324386-248EDD9D-31C7-4219-8243-3F3B4BDA4F65Q48052838-7A575043-5B17-4C8D-AE61-6631459EE072Q55063629-B930F509-2202-43F4-AA83-9F30B56540D5
P2860
Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Bacteria and irritable bowel s ...... testinal bacterial overgrowth.
@ast
Bacteria and irritable bowel s ...... testinal bacterial overgrowth.
@en
type
label
Bacteria and irritable bowel s ...... testinal bacterial overgrowth.
@ast
Bacteria and irritable bowel s ...... testinal bacterial overgrowth.
@en
prefLabel
Bacteria and irritable bowel s ...... testinal bacterial overgrowth.
@ast
Bacteria and irritable bowel s ...... testinal bacterial overgrowth.
@en
P1476
Bacteria and irritable bowel s ...... testinal bacterial overgrowth.
@en
P2093
Hyo-Rang Lee
P2860
P2888
P304
P356
10.1007/S11894-006-0051-3
P577
2006-08-01T00:00:00Z